<scp>HCV</scp>‐associated <scp>B</scp>‐cell non‐<scp>H</scp>odgkin lymphomas and new direct antiviral agents
Paul Carrier(Inserm), V. Loustaud‐Ratti(Hôpital Dupuytren), Denis Sautereau(Centre Hospitalier Universitaire de Limoges), Tessa Tabouret(Centre Hospitalier Universitaire de Limoges), Laura Mesturoux(Centre Hospitalier Universitaire de Limoges), Sophie Alain(Inserm), Jérémie Jacques(Centre Hospitalier Universitaire de Limoges), Marie Essig, Marilyne Debette‐Gratien(Inserm), Pierre Marquet(NeuroDevelopment Center), Julie Abraham(Centre Hospitalier Universitaire de Limoges), Arnaud Jaccard(Centre Hospitalier Universitaire de Limoges)
Cited by 62
Related Papers
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
|Journal of Clinical Oncology|2012|965
Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy
|The Lancet Infectious Diseases|2017|822
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration
|Nephrology Dialysis Transplantation|2020|411
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial
|Clinical Infectious Diseases|2021|299
Focused training for goal-oriented hand-held echocardiography performed by noncardiologist residents in the intensive care unit
|Intensive Care Medicine|2007|277